Cargando…
Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database
Background: Atypical hemolytic uremic syndrome (aHUS), an important cause of acute kidney injury (AKI), is characterized by dysregulation of the alternative complement pathway. Autoantibodies to factor H (FH), a chief regulator of this pathway, account for a distinct subgroup. While high anti-FH tit...
Autores principales: | Puraswani, Mamta, Khandelwal, Priyanka, Saini, Himanshi, Saini, Savita, Gurjar, Bahadur Singh, Sinha, Aditi, Shende, Rajashri Pramod, Maiti, Tushar Kanti, Singh, Abhishek Kumar, Kanga, Uma, Ali, Uma, Agarwal, Indira, Anand, Kanav, Prasad, Narayan, Rajendran, Padmaraj, Sinha, Rajiv, Vasudevan, Anil, Saxena, Anita, Agarwal, Sanjay, Hari, Pankaj, Sahu, Arvind, Rath, Satyajit, Bagga, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567923/ https://www.ncbi.nlm.nih.gov/pubmed/31231391 http://dx.doi.org/10.3389/fimmu.2019.01282 |
Ejemplares similares
-
Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome
por: Khandelwal, Priyanka, et al.
Publicado: (2018) -
Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection
por: Khandelwal, Priyanka, et al.
Publicado: (2022) -
Codon Usage Provide Insights into the Adaptation of Rice Genes under Stress Condition
por: Tyagi, Swati, et al.
Publicado: (2023) -
Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021) -
Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022)